ROCHESTER, Minn. -- Mayo Clinic released a new DNA product with Helix, a personal genomics company, called "Mayo Clinic GeneGuide." The DNA-powered product provides healthy...
NEW YORK...October 1, 2018 -- FDA-approved artificial sweeteners and sport supplements were found to be toxic to digestive gut microbes, according to a new paper...
Credit: Cleveland Clinic Monday, October 1, 2018, CLEVELAND: Cleveland Clinic is the first hospital in the country to successfully perform surgeries using the Single Port...
Washington, DC (October 1, 2018) -- The American Society of Nephrology (ASN) released a new analysis of the kidney health workforce that identifies practice setting...
Credit: University of Michigan ANN ARBOR, MI - Only a small percentage of people in their 50s and early 60s have had their DNA tested...
DALLAS, Oct. 1, 2018 -- Fluctuations in weight, blood pressure, cholesterol and/or blood sugar levels in otherwise healthy people may be associated with a higher...
A specific protein called TEAD1 is an important regulator of tumor migration in glioblastoma, the most common brain tumor in adults, and deactivating this protein...
For those in the habit of getting their neck adjusted by a chiropractor, the University of Michigan Kellogg Eye Center has interesting information to know...
SAN FRANCISCO - Sept. 30, 2018 - Evidence is mounting that a poor diet plays an important role in the development of age-related macular degeneration...
SINGAPORE, 1 October 2018 - The resistance of mosquito borne arboviruses such as dengue, zika, chikungunya and yellow fever are now a major threat to...
A team of eye specialists at The University of Nottingham has made another novel discovery that could help to improve the success of corneal transplants...
The health care systems in some European countries lack the capacity to rapidly move a disease-modifying treatment for Alzheimer's disease from approval into widespread clinical...
NEW YORK -- Angiosarcoma Project, a patient-partnered genomics study, identified immune checkpoint inhibition as a potential treatment option for patients with angiosarcomas of the head,...
NEW YORK -- Treatment with a HER2-targeted therapeutic cancer vaccine provided clinical benefit to several patients with metastatic HER2-positive cancers who had not previously been...
NEW YORK -- A phase I clinical trial investigating the use of bacterial Clostridium novyi-NT spores as an injectable monotherapy had manageable toxicities and showed...
